Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
  April 24, 2014


In This Edition
News Roundup: Metric of the Month: Risk-Based Monitoring
Articles: Centralized Statistical Monitoring to Improve the Quality of Clinical Data
Blog Posts: Amgen’s FSP Model & RBM: Doing it Right?
Marketplace: Marketplace


News Roundup
bullet Metric of the Month: Risk-Based Monitoring
bullet Take This Survey on Risk-Based Monitoring


Articles
bullet Centralized Statistical Monitoring as a Way to Improve the Quality of Clinical Data
bullet Risk-Based Monitoring Key to Protecting Data Integrity and Improving Patient Safety
bullet Risk-Based Monitoring eBook

Blogs Posts
bullet Amgen’s FSP Model & RBM: Doing it Right?
bullet RBM Approaches Taking Shape

Events
bullet PRO/COA Summit
 
CHINA REPORT
China is the third largest pharmaceutical market in the world and will become the second largest ahead of Japan by 2015. Everything you need to know to do business in the country; key economic sector data and exclusive interviews from regional leaders. Read More.

Follow Us

Ask The Editor

Lisa Henderson
Editor in Chief lhenderson@advanstar.com